[Dynamics of the humoral immunity indices in patients with subacute brucellosis being treated with levamisole].
The dynamics of the main characteristics of humoral immunity in patients with subacute brucellosis, receiving levamisole and placebo, has been studied. Levamisole produced an immunomodulating effect manifested by an increase in the number of B-lymphocytes and a drop in the level of circulating immune complexes. Levamisole did not essentially influence the content of serum immunoglobulins and specific antibodies.
D000208:Acute Disease; D000276:Adjuvants, Immunologic; D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D000918:Antibody Specificity; D000936:Antigen-Antibody Complex / Q000032:analysis; D001402:B-Lymphocytes / Q000276:immunology; D002002:Brucella / Q000276:immunology; D002006:Brucellosis / Q000188:drug therapy / Q000276:immunology*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D010919:Placebos
D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; D000936:Antigen-Antibody Complex; D007136:Immunoglobulins; D010919:Placebos; D007978:Levamisole
Dinamika pokazateleĭ gumoral'nogo immuniteta u bol'nykh podostrym brutsellezom v protsesse lecheniia levamizolom.